Laura Lovett

By Laura Lovett 03:32 pmJuly 12, 2019
Deep in the belly of the University of Helsinki, large metallic cylinders line a basement lab. While the setting is clinical, scientists have added a playful touch with snow-themed name tags on each of the vats. Still, the mission of the lab is serious — inside “snow queen” and “snow castle” lie genetic samples that could potentially help decode genetic variants responsible for disease. Finland...

Omada CEO Sean Duffy. Photo credit: Omada

By Laura Lovett 03:57 pmJuly 11, 2019
Omada Health, the digital health company that recently raised $73 million, came on to the digital health scene in 2011 with a focus on diabetes and chronic conditions. As the company continues to carve out its legacy in the digital health world, it is taking a cue from a more established industry. “We’re one of the most life sciences-like digital health companies. We don’t fit perfectly into any...
By Laura Lovett 03:51 pmJuly 10, 2019
Nurx, the San Francisco-based startup best known for providing contraceptives via telemedicine, has just added a new home STI testing option to its slew of services.  The new offerings, which were first spotted by TechCrunch, will allow potential clients to fill out an online questionnaire to receive an STI test kit in the mail. The kit comes with instructions and tools.  There are three STI...
By Laura Lovett 01:31 pmJuly 10, 2019
XRHealth, a digital health startup best known for its virtual reality technology, is now opening up its platform to third-party developers, the Boston-based company exclusively announced to MobiHealthNews.  The end goal will be a tool kit for providers, payers and pharmas that will serve as a “one-stop shop” for VR products.  The company, formerly known as VRHealth, is no stranger to developing...
By Laura Lovett 02:51 pmJuly 9, 2019
This morning precision medicine company GNS Healthcare announced a $23 million Series D raise. This latest investment round was led by Cigna Ventures with participation from Amgen Ventures, Celegene, Echo Health Ventures, Alexandria Venture Investments and Gary Loveman, the former CEO of Caesar and division president of Aetna.  WHAT THEY DO The company’s platform, dubbed REFS (Reverse Engineering...
By Laura Lovett 03:31 pmJuly 8, 2019
Pharmaceutical company UCB and DEARhealth, a disease management software company, are joining forces on a new initiative aimed at predicting health outcomes for patients with epilepsy. The pair will use DEARhealth’s platform, which integrates artificial intelligence with EHRs. “This technology will ensure that specific subpopulations within epilepsy will all receive the specific care needed for...
By Laura Lovett 01:50 pmJuly 3, 2019
Diving deeper into digital, this quarter the pharma giants have continued to implement new tools to enhance clinical trials, support medication management with technology and partner in developing digital therapeutics.  Onc, a foreign entity to this established industry, pharma executives are now becoming better versed in working with digital health companies and sharing the lessons they've...
By Laura Lovett 03:33 pmJuly 2, 2019
Cedars-Sinai has unveiled its latest accelerator class, which features startups the run the gamut of workflow management systems to remote patient monitoring systems and clinical trial data tools to augmented reality education. The next step for the 11 startups selected is a three-month stint at Cedars-Sinai’s Los Angles hospital to work with clinicians and administration teams.  Each of the...
By Laura Lovett 01:47 pmJuly 2, 2019
Getting mental health services to youth facing homelessness can pose a host of access challenges. But a new study published in JMIR found that smartphone-based mental health programs could be a viable approach to reaching this vulnerable population. In a small pilot, researchers found that more than half of the participants were engaging with the technology. While clinical improvements were...
By Laura Lovett 04:15 pmJuly 1, 2019
It would be hard to discuss healthcare trends without talking about what this means for the behemoth pharma industry. Recently, new kid on the block digital health has started to turn heads in across this well-established sector with its potential for improving R&D, tracking real-world evidence and even creating a new type of medicine with digital therapeutics.  While digital promises the...